Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique
| Autor: | Binbin Cong, Rong-Rong Zhao, Peng-Fei Qiu, Yan-Bing Liu, Guo-Ren Yang, Peng Chen, Yong-Sheng Wang |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
medicine.medical_specialty Axillary lymph nodes medicine.medical_treatment Sentinel lymph node Breast Neoplasms Metastasis Biopsy medicine Humans Aged Neoplasm Staging Aged 80 and over medicine.diagnostic_test Sentinel Lymph Node Biopsy business.industry Cancer Clinical Trial/Experimental Study General Medicine Middle Aged medicine.disease Radiation therapy Axilla medicine.anatomical_structure Lymphatic Metastasis Technetium Tc 99m Sulfur Colloid Female Lymph Nodes Lymph Radiology Radiopharmaceuticals business Lymphoscintigraphy Research Article |
| Zdroj: | Medicine |
| ISSN: | 0025-7974 |
| DOI: | 10.1097/md.0000000000001790 |
| Popis: | Although the 2009 American Joint Committee on Cancer incorporated the internal mammary sentinel lymph node biopsy (IM-SLNB) concept, there has been little change in surgical practice patterns because of the low visualization rate of internal mammary sentinel lymph nodes (IMSLN) with the traditional radiotracer injection technique. In this study, various injection techniques were evaluated in term of the IMSLN visualization rate, and the impact of IM-SLNB on the diagnostic and prognostic value were analyzed. Clinically, axillary lymph nodes (ALN) negative patients (n = 407) were divided into group A (traditional peritumoral intraparenchymal injection) and group B (modified periareolar intraparenchymal injection). Group B was then separated into group B1 (low volume) and group B2 (high volume) according to the injection volume. Clinically, ALN-positive patients (n = 63) were managed as group B2. Internal mammary sentinel lymph node biopsy was performed for patients with IMSLN visualized. The IMSLN visualization rate was significantly higher in group B than that in group A (71.1% versus 15.5%, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|